🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 10 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 31/01/1975 | 1,69 | 1,70 | 1,66 | 1,68 | -0,58% | 1,96% | 3.448.339 |
| 30/01/1975 | 1,74 | 1,79 | 1,69 | 1,69 | -2,85% | 5,70% | 3.048.422 |
| 29/01/1975 | 1,69 | 1,75 | 1,68 | 1,74 | +3,34% | 3,93% | 2.263.680 |
| 28/01/1975 | 1,71 | 1,74 | 1,68 | 1,69 | -1,17% | 3,49% | 3.372.883 |
| 27/01/1975 | 1,67 | 1,71 | 1,67 | 1,71 | +3,41% | 1,98% | 3.331.382 |
| 24/01/1975 | 1,63 | 1,65 | 1,63 | 1,65 | +1,43% | 1,63% | 1.731.715 |
| 23/01/1975 | 1,63 | 1,66 | 1,61 | 1,63 | +0,00% | 3,06% | 1.180.886 |
| 22/01/1975 | 1,56 | 1,63 | 1,55 | 1,63 | +4,25% | 5,09% | 2.652.278 |
| 21/01/1975 | 1,56 | 1,58 | 1,55 | 1,56 | +0,21% | 1,91% | 2.256.134 |
| 20/01/1975 | 1,56 | 1,58 | 1,52 | 1,56 | -0,21% | 3,40% | 3.105.014 |
| 17/01/1975 | 1,63 | 1,63 | 1,56 | 1,56 | -4,27% | 4,67% | 3.048.422 |
| 16/01/1975 | 1,64 | 1,67 | 1,63 | 1,63 | -0,40% | 2,43% | 1.927.901 |
| 15/01/1975 | 1,63 | 1,64 | 1,57 | 1,64 | +0,40% | 4,26% | 2.969.194 |
| 14/01/1975 | 1,66 | 1,66 | 1,62 | 1,63 | -2,18% | 2,39% | 1.656.259 |
| 13/01/1975 | 1,69 | 1,72 | 1,66 | 1,67 | -1,18% | 3,53% | 2.278.771 |
| 10/01/1975 | 1,70 | 1,74 | 1,67 | 1,69 | -0,59% | 4,10% | 3.203.107 |
| 09/01/1975 | 1,71 | 1,71 | 1,66 | 1,70 | -1,91% | 3,29% | 2.950.330 |
| 08/01/1975 | 1,76 | 1,77 | 1,72 | 1,73 | -1,51% | 2,83% | 1.924.128 |
| 07/01/1975 | 1,79 | 1,82 | 1,76 | 1,76 | -2,03% | 3,51% | 1.501.574 |
| 06/01/1975 | 1,79 | 1,84 | 1,78 | 1,79 | +0,00% | 2,96% | 1.305.389 |
| 03/01/1975 | 1,78 | 1,81 | 1,76 | 1,79 | +0,56% | 2,60% | 988.474 |
| 02/01/1975 | 1,76 | 1,81 | 1,76 | 1,78 | +1,32% | 2,45% | 1.648.714 |
| 31/12/1974 | 1,70 | 1,76 | 1,70 | 1,76 | +4,12% | 3,71% | 1.252.570 |
| 30/12/1974 | 1,69 | 1,69 | 1,67 | 1,69 | -0,39% | 1,37% | 1.380.845 |
| 27/12/1974 | 1,74 | 1,74 | 1,68 | 1,70 | -2,66% | 3,80% | 3.520.022 |
| 26/12/1974 | 1,79 | 1,81 | 1,73 | 1,74 | -2,59% | 4,26% | 2.878.646 |
| 24/12/1974 | 1,77 | 1,79 | 1,77 | 1,79 | +1,12% | 0,93% | 565.920 |
| 23/12/1974 | 1,76 | 1,78 | 1,75 | 1,77 | +0,37% | 2,07% | 1.535.530 |
| 20/12/1974 | 1,77 | 1,78 | 1,75 | 1,76 | -0,37% | 1,50% | 980.928 |
| 19/12/1974 | 1,78 | 1,79 | 1,76 | 1,77 | -0,38% | 1,86% | 1.116.749 |